mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.05 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |